RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      SCOPUS KCI등재

      관상동맥질환 치료를 위한 생체흡수형스텐트의 개발 동향 = The Developing Trend in Bioresorbable Stent for Treatment of Coronary Artery Disease

      한글로보기

      https://www.riss.kr/link?id=A105677894

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The coronary artery disease (CAD) is rapidly increasing such as angina pectoris and atherosclerosis. The CAD is induce by cholesterol and calcium like plaque absortion to artery wall. The percutaneouss coronary intervention is non-invasive treatment that narrowed-artery is expand by using balloon catheter and bare metallic stent. The metallic stents have been effective in reducing the dead by coronary artery disease, but the permanent presence of the metallic stent has been associated with persistent inflammation, and incidence of late thrombosis. Therefore, development bioresorbable vascular scaffold (BRS) is rapidly increasing for treatment of long-term complications and arterial restenosis by permanentmetal prosthesis such as stent. The review discusses the BRS trend for successfully development.
      번역하기

      The coronary artery disease (CAD) is rapidly increasing such as angina pectoris and atherosclerosis. The CAD is induce by cholesterol and calcium like plaque absortion to artery wall. The percutaneouss coronary intervention is non-invasive treatment t...

      The coronary artery disease (CAD) is rapidly increasing such as angina pectoris and atherosclerosis. The CAD is induce by cholesterol and calcium like plaque absortion to artery wall. The percutaneouss coronary intervention is non-invasive treatment that narrowed-artery is expand by using balloon catheter and bare metallic stent. The metallic stents have been effective in reducing the dead by coronary artery disease, but the permanent presence of the metallic stent has been associated with persistent inflammation, and incidence of late thrombosis. Therefore, development bioresorbable vascular scaffold (BRS) is rapidly increasing for treatment of long-term complications and arterial restenosis by permanentmetal prosthesis such as stent. The review discusses the BRS trend for successfully development.

      더보기

      참고문헌 (Reference)

      1 M. C. Chen, "The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents" 30 : 79-88, 2009

      2 B. Gogas, "The ABSORB bioresorbable vascular scaffold an evolution or reverlution in interventional cardiology" 53 : 301-309, 2012

      3 G. L. Buchanan, "Stent thrombosis: incidence, predictors and new technologies" 2012 : 956-962, 2012

      4 A. Abizaid, "Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve novolimus-eluting bioresorbable coronary scaffold system for the treatment of single de novo coronary lesions" 9 : 565-574, 2016

      5 E. Tenekecioglu, "Randomized comparsion of Absorb bioresorbable vascular scaffold and Mirage microfiber sirolimus-eluting scaffold using multimodality imaging" 10 (10): 1115-1130, 2017

      6 C. Landau, "Percutaneous transluminal coronary angioplasty" 330 : 981-993, 1994

      7 D. Regazzoli, "New generation bioresorbable scaffold technologies: An update on novel devices and clinical results" 9 : 979-985, 2017

      8 C. Rapetto, "Margmaris: A new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and futrue perspectives" 9 : S903-S913, 2017

      9 A. S. Rao, "Long-term otucomes of internal carotid artery dissection" 40 : 499-504, 2009

      10 S. A. Park, "In vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3D-printing system" 141 : 355-358, 2015

      1 M. C. Chen, "The characteristics and in vivo suppression of neointimal formation with sirolimus-eluting polymeric stents" 30 : 79-88, 2009

      2 B. Gogas, "The ABSORB bioresorbable vascular scaffold an evolution or reverlution in interventional cardiology" 53 : 301-309, 2012

      3 G. L. Buchanan, "Stent thrombosis: incidence, predictors and new technologies" 2012 : 956-962, 2012

      4 A. Abizaid, "Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve novolimus-eluting bioresorbable coronary scaffold system for the treatment of single de novo coronary lesions" 9 : 565-574, 2016

      5 E. Tenekecioglu, "Randomized comparsion of Absorb bioresorbable vascular scaffold and Mirage microfiber sirolimus-eluting scaffold using multimodality imaging" 10 (10): 1115-1130, 2017

      6 C. Landau, "Percutaneous transluminal coronary angioplasty" 330 : 981-993, 1994

      7 D. Regazzoli, "New generation bioresorbable scaffold technologies: An update on novel devices and clinical results" 9 : 979-985, 2017

      8 C. Rapetto, "Margmaris: A new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and futrue perspectives" 9 : S903-S913, 2017

      9 A. S. Rao, "Long-term otucomes of internal carotid artery dissection" 40 : 499-504, 2009

      10 S. A. Park, "In vivo evaluation and characterization of a bio-absorbable drug-coated stent fabricated using a 3D-printing system" 141 : 355-358, 2015

      11 W. Schmidt, "In vitro performance investigation of bioresorbable scaffolds-Standard test for vascular stents and beyond" 17 : 375-383, 2016

      12 Y. C. Lee, "Health Industry Brief Medical Device Market Statistics: Stent" 52 : 1-20, 2017

      13 M. Ying, "Gloval Bioresorbable Vascular Scaffold Sales Market Report 2017" QYResearch 1-129, 2017

      14 T. P. Vahl, "Four-year polymer biocompatiblity and vascular scaffold: An OCT study in healthy procine coronary arteries" 12 : 1510-1518, 2016

      15 A. Seth, "First-in-human evaluation of a novel poly(L-lactide) based sirolimus-eluting bioresrobable vascular scaffold for the treatment of de novo native coronary artery lesions: meRes-1 trial" 13 : 415-423, 2017

      16 A. Abizaid, "First report on the pivotal DESolve Nx trial: 6-month clinical and multi-modality imaging results" 2013

      17 P. W. Serruys, "Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months" 9 (9): 1271-1284, 2014

      18 H. Hermawan, "Developments in metallic biodegradable stents" 6 : 1693-1697, 2010

      19 Y. Wu, "Comparison of acute recoil between bioabsorbable poly(L-lactic acid) XINSORB stent and metallic stent in porcine model" 2012 : 1-8, 2012

      20 H. Y. Ang, "Bioresrobable stent: Current and upcoming bioresorbable technologies" 228 : 931-939, 2017

      21 C. Campos, "Bioresorbable vascular scaffolds in the clinical setting" 5 : 639-646, 2013

      22 J. Iqbal, "Bioresorbable scaffolds: rationale, current status, challenges, and future" 35 : 765-776, 2014

      23 Y. Zhang, "Bioresorbable scaffolds in the treatment of coronary artery disease" 6 : 37-48, 2013

      24 B. D. Gogas, "Bioresorbable scaffolds for percutaneous coronary interventions" 40 : 409-427, 2014

      25 B. D. Gogas, "Bioresorbable scaffolds for percutaneous coronary interventions" 40 : 409-427, 2014

      26 S. McMahon, "Bio-resorbable polymer stents: a review of material progress and prospects" 83 : 79-96, 2018

      27 P. Staehr, "ABSORB bioresorbable vascular scaffold system" 2012

      28 S. Verheye, "A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation" 7 : 89-99, 2014

      29 A. Abizaid, "6-Month clinical and angiographic outcomes of a novel radio radiopaque sirolimus-eluting bioresorbable vascualr scaffold: the FANTOM II study" 10 : 1832-1838, 2017

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2013-12-01 평가 SCOPUS 등재 (등재유지) KCI등재
      2011-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-02-19 학술지명변경 외국어명 : Journal of the Korean Industrial and Engineering Chemistry -> Applied Chemistry for Engineering KCI등재
      2009-04-28 학술지명변경 외국어명 : Jpurnal of the Korean Industrial and Engineering Chemistry -> Journal of the Korean Industrial and Engineering Chemistry KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.32 0.32 0.34
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.33 0.33 0.45 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼